Australia markets closed

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.3900-0.0500 (-2.05%)
At close: 04:00PM EDT
2.3900 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CHF. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-73,280
-54,233
-70,753
-72,996
-61,921
Depreciation & amortisation
2,382
2,215
2,359
2,406
1,967
Stock-based compensation
3,486
4,365
3,330
4,126
4,088
Change in working capital
-4,631
-15,160
-8,432
6,841
-4,573
Accounts receivable
-14,800
-14,800
0
0
-
Other working capital
-75,909
-61,209
-74,807
-68,324
-61,223
Other non-cash items
-2,038
1,098
-204
-6,196
551
Net cash provided by operating activities
-73,989
-60,408
-73,568
-65,689
-59,517
Cash flows from investing activities
Investments in property, plant and equipment
-1,920
-801
-1,239
-2,635
-1,706
Other investing activities
2
-
2
-29
-29
Net cash used for investing activities
-2,918
65,645
23,763
-53,664
28,329
Cash flows from financing activities
Debt repayment
-570
-548
-569
-513
-946
Common stock issued
4,345
43,798
7
17,802
100
Common stock repurchased
-
-
-8
0
-100
Other financing activities
-
-
-776
-6
-
Net cash used provided by (used for) financing activities
27,538
43,250
-1,346
40,746
-803
Net change in cash
-49,369
48,487
-51,151
-78,607
-31,991
Cash at beginning of period
93,584
31,586
82,216
160,893
193,587
Cash at end of period
44,215
78,494
31,586
82,216
160,893
Free cash flow
Operating cash flow
-73,989
-60,408
-73,568
-65,689
-59,517
Capital expenditure
-1,920
-801
-1,239
-2,635
-1,706
Free cash flow
-75,909
-61,209
-74,807
-68,324
-61,223